Dilon Technologies Inc.
Model MarginProbe - Clean Margins Matter
Clinically stated, the objective is a clean, negative margin, with all six surfaces of an excised tumor cancer-free. MarginProbe makes possible lumpectomy margin assessment while in the operating room.
Most popular related searches
With MarginProbe, surgeons can assess the tissue in the operating room to give them greater confidence that they successfully removed all the cancer in the first lumpectomy surgery.
With MarginProbe, surgeons can identify positive margins in real-time on the lumpectomy specimen enabling them to take additional tissue during the first lumpectomy surgery.
The technology uses radio-frequency (RF) electrical fields to probe the tissue in order to identify any cancer that may be remaining on the surface of the tissue removed from the breast. If MarginProbe identifies cancer on the surface of the tissue the surgeon will remove additional tissue from the breast at the time of surgery.